MAIA Biotechnology CEO and Director Purchase Company Shares on Open Market

MAIA Biotechnology announced on Tuesday that its Chief Executive Officer and a member of its Board of Directors purchased shares of the company’s common stock on the open market. These transactions represent the latest insider activity for the biotechnology firm, as company leadership acquired additional equity stakes in the organization.

The company confirmed that CEO Mohammad Azab and Director Vladislav Sandler executed the purchases to increase their respective holdings. Regulatory filings associated with the trades detail the specific volume of shares acquired and the price points at which the transactions occurred. These disclosures follow standard reporting requirements for corporate insiders, providing transparency regarding the financial interests of the company’s executive team and board members.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 2, 2026

Author

GOAI